Introduction
Tissue remodeling is by definition the reorganization or renovation of existing tissues. This is a process which is required to maintain normal tissue homeostasis and repair damaged tissue.
Remodeling occurs in all inflammatory responses although the mechanism and severity vary depending on the disease (1, 2) .
Allergic asthma is a chronic inflammatory disease involving ongoing inflammation and repair leading to structural airway remodeling. Although multiple mediators and growth factors such as Th2 cytokines, TGF-beta, MMP-9, ADAM-33 and VEGF have been considered to influence the airway remodeling process, currently there are no reliable clinical characteristics or surrogate markers that could identify lower airways remodeling (3) .
Structural changes that are implicated in lower airways remodeling such as epithelial shedding, thickening of basement membrane, angiogenesis, smooth muscle hypertrophy and deposition of collagens with subepithelial fibrosis are the features which are considered to contribute to airway obstruction and bronchial hyperreactivity (4) (5) (6) .
In allergic rhinitis, remodeling has received scarce interest and is not well understood. There are very few studies that investigate upper-airway structural remodeling in the nasal mucosa of allergic rhinitis and data is conflicting. It was reported that perennial allergic rhinitics had increased vascularity in nasal mucosa compared to healthy controls (7), while another study examined lower and upper airways of perennial allergic rhinitis patients with and without asthma and compared them with healthy controls (8) . In this study, it was demonstrated that even though similar inflammatory changes were present in both lower and upper airways of allergic rhinitis with and without asthma, no evidence of structural changes such as reticular basement thickness, epithelial desquamation and vascularity; was found in upper airways in allergic rhinitis as compared to healthy controls. 7 staining vascular (CD31) and lymphatic endothelial (D2-40) cells, and vascular endothelial growth factor-A (VEGF-A). Furthermore, extracellular matrix activation was evaluated by quantification of fibroblasts, alpha-SMA, MMP-7, MMP-9 and tissue inhibitor of metalloproteinase-1 (TIMP-1). Epithelial integrity and RBM were assessed using haematoxylin stained slides. Epithelial goblet cells and the glandular mucus area were evaluated using PAS staining. The collagen content was assessed by picrosirius red staining (12) . Biopsies were coded and evaluated blindly by three investigators without the knowledge of clinical characteristics.
Nasal mucosal inflammatory cells, were quantified using a BH-2 Olympus microscope.
Epithelial integrity was scored on 0-4 scale, with 4 being an intact epithelium. Vascular and lymphatic staining was assessed using computer assisted image analysis (Image Pro-Plus 7.0 system, Media Cybernetics, Inc). The whole specimen was captured at x200 magnification, using Nikon 80i light microscope coupled to colour camera (QImaging, Media Cybernetics, Inc) that transmits the image to a computer. Epithelial and sub-mucosal mucus glands, total sub-mucosal and vascular area were measured separately using computer image analysis.
Reticular basement membrane thickness was measured as proposed by Sullivan et al (13) .
Epithelial and sub-mucosa cell counts were expressed as the number of positively stained nucleated cells per mm , and the vessel number (per mm 2 ) within the total area of assessed sub-mucosa were evaluated. Percentage vascular area was calculated as [(total vascular area/sub-mucosal area)
x 100]; number of blood vessels/mm 2 (vessels density) as (total number of blood vessels/ total sub-mucosal area); and mean vessel size/mm 2 (total vascular area/total number of blood vessels). Furthermore, the relative lymphatic vessel density was studied by calculating the ratio of D2-40/CD31 positive vessels/mm 2 (see supplement).
Picrosirius stained collagens were quantified as previously described (12) . Briefly, color images of two sections from each biopsy were acquired at x200 magnification (with a polarizing lens for picrosirius red-stained sections; Leica QWin version 3). Subsequently, images were converted to grayscale, and the area of positive staining that includes reticular basement membrane and whole of sub-mucosa was determined at a preset pixel intensity by using the Leica QWin software. The mean area of collagen and total sub-mucosal area was used to calculate the percentage area of collagen in each nasal biopsy.
Statistics
Values are presented as median [IQ 25-75 range], unless otherwise specified. Comparisons for quantitative variables were performed by non-parametrical analysis, Mann-Whitney U test for non-related samples. Differences between three groups were assessed using KruskalWallis test (nonnormal distribution) followed by Dunn's multiple comparisons test. Withingroup comparisons were performed using the Wilcoxon matched-pairs signed-rank test.
Interobserver reproducibility was measured using Bland-Altman test, acceptable results were within 2 standard deviation. All tests were two-tailed. Significance was set at P<0.05.
GraphPad Prism 5 Project software was used for analysis (see supplements statistics).
Results

Subjects
The demographic characteristics of the participants are summarised in Table 1 (see   supplement) . Among 46 persistent allergic rhinitics (PAR) subjects evaluated during the grass pollen season, 23 had a history of severe seasonal allergic rhinitis symptoms sensitised to Timothy grass and the other 23 had moderate-severe perennial symptoms and were sensitized to house dust mite (see supplement Table 2 ). Nineteen subjects were non-atopic healthy controls. Thirty one percent of PAR had current eczema or asthma (Table 1) . [3] [4] [5] [6] [7] p<0.001, respectively) (Fig 1) . Subgroup analysis showed IL-4, IL-5 and IL-13 were significantly higher in seasonal allergic rhinitis compared to healthy controls (p=0.02, p<0.001, and p<0.0001, respectively), while perennial allergic rhinitis had higher nasal lavage IL-4 and IL-5 levels compared to healthy controls (p=0.04 and p<0.01, respectively). However, there was no difference in the levels of IL-10
Nasal symptoms, Visual analogue and Total Quality of Life scores
and IFN-γ between PAR and healthy controls or on subgroup analysis (data not shown).
Nasal mucosal inflammatory cells
The numbers of MBP + eosinophil were increased in the PAR group compared to controls, p=0.06, Fig 1 ( for seasonal allergic rhinitis increases in eosinophils were significant, p=0.04).
No changes in either mast cell or basophil numbers were observed in PAR group compared to healthy controls or when comparing subgroups and healthy controls (data not shown).
Analysis of Epithelium, Reticular basement membrane and Glands
The epithelial integrity and RBM thickness showed no difference between PAR and healthy controls (Table 2) . Furthermore, total epithelial mucus and sub-mucosal glandular percentage area were similar in both groups (Fig 2 A & (Table 2) .
Furthermore, on subgroup analysis no differences were observed when comparing seasonal, perennial and healthy controls in terms of blood and lymphatic endothelial positive cells, total vascular numbers, vascular area or mean vascular size for both blood and lymphatic vessels.
There was also no difference in lymphatic vessel density on subgroup analysis (supplement table 3 ).
Sub-mucosal Extracellular and Collagen Markers
Expression of sub-mucosal MMP-7, MMP-9 and TIMP-1 were not significantly different between PAR and healthy controls (Fig 3 A-F , Table 2 ). The ratio of MMP9/TIMP-1 was not significantly different between the two groups. No difference was observed when comparing between seasonal, perennial and healthy controls for all analysed extracellular matrix protein markers. On comparing seasonal allergic rhinitis subjects during and out of season, a significant increase in TIMP-1 was observed in out of season biopsies compared to during pollen season, while no changes were observed for MMP-7 and MMP-9 when seasonal allergic subjects were compared in season and out of season (supplement table 3 ).
The expression of nasal mucosal fibroblasts (Fig 4 A,B ) and α-SMA cell numbers (Fig 4 C,D) were not significantly different between PAR and healthy controls ( 
Discussion
The current study demonstrated that persistent allergic rhinitis is characterised by increased levels of local nasal secretion of IL-4, IL-5 and IL-13 Th2 cytokines and local tissue eosinophilia but no structural changes nor evidence of remodelling. Epithelial integrity, reticular basement membrane thickness and the nasal mucosal glandular area were not different between PAR and controls. Furthermore, there was no difference in blood and lymphatic vascularity, fibrosis or collagen deposition nor degradation of extracellular matrix markers observed between the groups. In contrast to asthma, remodeling is not a feature of allergic rhinitis. This questions the current dogma on the relation between the upper and lower airways and argues that in contrast to asthma, targeting remodeling in allergic rhinitis may not be appropriate as a therapeutic approach.
To our knowledge, this is the first study to compile and evaluate the expression of remodeling-related proteins in the upper-airways of allergic rhinitis patients looking both in nasal lavage and nasal biopsies in one setting. The current study included adequate sample size and used strict inclusion criteria to ensure that a well characterised group of subjects with moderate to severe persistent allergic rhinitis according to Aria guidelines could be observed alongside a group of normal healthy controls.
Lower airway remodeling is considered to occur due to chronic inflammation and eosinophils are thought to be the cells that orchestrate the production of cytokines, growth factors and mediators leading to proliferation and differentiation of fibrotic cells that leads to collagen deposition and tissue fibrosis (14-16). The current study found an increase in Th2 cytokines within nasal secretions and sub-mucosal eosinophils in persistent allergic rhinitis confirming a local intense inflammation. This corresponds to our previous finding that both seasonal (17, 18) and perennial allergic rhinitis (19) are associated with an increase in tissue eosinophils and with an increase in nasal mucosal cells expressing mRNA for the Th2-type cytokines compared to healthy controls. This is in line with previous studies that compared nasal and bronchial tissue with eosinophilia in persistent allergic rhinitis and found that the upper airway has similar intense inflammation compared to lower airways in the same individuals (8, 20) but that the chronic inflammation didn't alter upper airway mucosal structural changes (21) . Hence, the present study confirms that although there is allergic inflammation in the upper airways of PAR subjects, remodeling changes such as epithelial integrity loss, RBM thickness, nasal tissue glandular hypertrophy, vascularity and collagen or extracellular matrix deposition are indistinguishable between PAR and healthy controls.
It has been well documented that angiogenesis is a characteristic feature of remodeling in asthma (22, 23) . Although increased vascular permeability is observed in allergic rhinitis (24),
evidence showing angiogenesis or gross structural vascular changes are lacking. Our data confirms previously published reports (8, 25) showing no difference in the total number of CD31 + cells, blood vessels, vascular density nor mean vascular size in the nasal mucosa of allergic rhinitics compared to controls. Furthermore, on evaluating angiogenic growth factors, there were no changes in the upregulation of VEGF-A expressing cells or their stained vessels in the nasal mucosa observed between the groups. In addition, using D2-40 staining which is considered a sensitive and specific marker for lymphatic endothelium (26) , no difference in the numbers, density or mean volume of lymphatic vessels was observed between the two groups. Taken all together, our study does not indicate that angiogenesis or lymphangiogenesis is the feature of upper airway remodeling in allergic rhinitics.
Matrix metalloproteinases are major proteolytic enzymes that are involved in extracellular matrix turnover. We examined MMP-7 and MMP-9 because they are believed to cleave major collagen components of extracellular matrix and basement membrane. The extracellular activity of MMPs is regulated by TIMPs, which are produced by the same cell types that produce MMPs, and TIMP-1 has been implicated as a natural inhibitor of both MMP-7 and 9 (27) (28) . It has been shown that MMP7 and 9 is upregulated in chronic rhinosinusitis with or without polyps (29) and the ratio of MMP-9/TIMP-1 is increased in asthmatics (30) (31) . Recently it has been demonstrated that only MMP-9 but not MMP-2 or TIMP-1 mRNA expression is increased in nasal mucosa of severe perennial allergic rhinitis compared to mild rhinitics and healthy controls (32). We had anticipated that patients with PAR would have increased expression of MMPs and an imbalance of TIMP. However, in the present study we did not find any difference in MMP-7, MMP-9 or TIMP-1 between PAR and healthy controls. This is in line with previous reports that found no significant difference in both protein and mRNA transcript levels of MMP-9 or TIMP-1 in the nasal mucosa of perennial allergic rhinitis compared to healthy controls (33) .
Subepithelial fibrosis is an important feature of airway remodeling in asthma which is attributable to an increased deposition of extracellular matrix (34) . Fibroblasts and myofibroblasts are the main sources of extracellular matrix proteins in the airways subepithelial fibrosis with TGF-beta being the main player that promotes differentiation of fibroblasts to myo-fibroblasts phenotypes (those expressing α -SMA) triggering their proliferation (31, 35, 36) . We found a similar degree of expression of HSP-47 + fibroblasts cells and α -SMA + cells in both PAR and healthy controls. In addition, total collagen area was the same in both PAR and healthy control nasal mucosa. Thickening of RBM due to deposition of collagens is a common feature of asthmatic airway remodeling, however the present study demonstrated no difference in changes in nasal mucosal subepithelial basement membrane between healthy and PAR patients confirming that there is no upper-airway structural difference between allergic rhinitics compared to healthy individuals. Recently, it has been shown in an in-vitro study that TGF-beta enhances expression of both α-SMA and collagen production in lung fibroblasts but not in nasal polyp fibroblasts highlighting the heterogeneous response of fibroblasts in the airway to TGF-beta between the upper and lower airway tissues (37).
Recent studies have suggested that structural airway changes in asthmatics can occur after resolution of or in the absence of inflammation due to the induction of epithelial stress by airway hyperreactivity which initiates bronchial airway remodeling (38,39). Hence supporting the emerging concept that the epithelial-mesenchymal trophic unite (EMTU), the embryologic unit driving airway development, is being reactivated in airway remodeling through genetic and environmental interactions. This concept suggests that activated airway Our result are also in line with recent data that showed treating chronic sinonasal disease does not improve asthma control (43,44). Hence, our results might support the notion that either the upper airways respond differently to allergic inflammation than the lower airways or that there are factors other than eosinophils or Th2 cytokines which drive the response in the lower airways.
In conclusion, our data suggests that despite the presence of Th2 allergic inflammation in persistent allergic rhinitis, there is no upper airway structural remodeling compared to healthy subjects. The impact of our findings is that in contrast to asthma, structural changes and remodeling are not features of allergic rhinitis. This questions the current dogma on the relation between the upper and lower airways and argues that in contrast to asthma, targeting remodeling in allergic rhinitis may not be appropriate as a therapeutic target. 
Study design
Each subject was required to make 2 separate visits. After the screening visit eligible 
Symptoms scores, Visual analogue score and quality of life
Symptoms scores were evaluated using a four-point scoring system: 0 (no symptoms) to 3
(severe symptoms) for each rhinitis symptom (sneezing, nasal discharge, itching and nasal obstruction). Subjects were asked to score their symptoms when they were most severe during the last week. The total score of all four rhinitis symptoms was termed the total nasal symptom score (TNSS) (maximum 12 points). Total nasal symptom scores were recorded before collection of nasal lavage and biopsy procedures. Quality of life in relation to symptoms was assessed using mini Rhinitis Quality of Life Questionnaires (mRQLQs).
Participants were asked to mark a visual analogue scale (scale 0-100 mm) documenting the overall severity of their allergic rhinitis symptoms during the past week.
Nasal Lavage procedure and measurement of nasal lavage cytokine levels
Subjects were seated in a forward-flexed neck position to prevent fluid from reaching the nasopharynx. To ensure adequate washing, the lavage fluid (5 ml of PBS) was passed slowly into the nasal cavity via an olive consisting of an oval, hollow, stainless steel device that was used to obstruct the nostril. The fluid was withdrawn into the syringe and gently flushed back into the nasal cavity 20 times over 1 minute. Samples were centrifuged (4 0 C, 10 minutes at 0 C). For the electrochemiluminescence studies, the levels of IFN-γ, IL-4, IL-5, IL-10, and IL-13 in the nasal lavage samples were analyzed in duplicates using the Human TH1/TH2 10-plex UltraSensitive kit from Meso Scale Discovery (MSD, Gaithersburg, MD). Assays were conducted according to standard manufacturer's protocols. MSD plates were analysed on the Sector
Imager 6000 using MSD Discovery workbench software (v 3.0.17.3). According to manufacturer's protocol, the lower limit of detection for IL-4:0.31 pg/mL, IL5: 0.076 pg/mL, IL-13: 1.8 pg/mL, IL10: 0.36 pg/mL, and IFN-γ: 0.39 pg/mL.
Nasal Biopsies, immunohistochemistry staining and quantification
Nasal biopsies specimens (2.5 mm) were taken from the under surface of the inferior turbinate using Gerritsma forceps with lidocaine 5% and phenylephrine 0.5% mixture nasal spray and 10% cocaine as local anaesthetic as described previously (E-2). Tissue specimens were fixed in 4% paraformaldehyde for 2 hours, then dehydrated in 15% sucrose for 1 h and then again overnight, before being embedded in OCT and snap frozen. Five-micron sections were cut and slides were dried overnight at 37 0 C and then stored at -80 0 C.
Immunohistochemistry staining and quantification
Immunohistochemistry was performed using the Vectastatin avidin/biotin complex-alkaline phosphatase (ABC-AP) method as described previously (E-2). Briefly, sections were incubated with 20% horse serum in PBS for 30 minutes to reduce non-specific binding.
Mouse monoclonal primary antibodies were applied to slides using pre-determined dilutions (E- Table 1 Nasal mucosal inflammatory cells, were quantified using a BH-2 Olympus microscope.
Epithelial integrity was scored on 0-4 scale, with 4 being an intact epithelium. Vascular and lymphatic staining was assessed using computer assisted image analysis (Image Pro-Plus 7.0 system, Media Cybernetics, Inc). The whole specimen was captured at x200 magnification, using Nikon 80i light microscope coupled to colour camera (QImaging, Media Cybernetics, Picrosirius stained collagens were quantified as previously described (E-3). Briefly, colour images of two sections from each biopsy were acquired at x200 magnification (with a polarizing lens for Picrosirius red-stained sections; Leica QWin version 3). Subsequently, images were converted to grayscale, and the area of positive staining that includes reticular 7 basement membrane and whole of sub-mucosa was determined at a preset pixel intensity by using the Leica QWin software. The mean area of collagen and total sub-mucosal area was used to calculate the percentage area of collagen in each nasal biopsy. Interobserver reproducibility within 2 standard deviation was measured using Bland-Altman test. All tests were two-tailed. Significance was set at P<0.05. GraphPad Prism 5 Project software was used for analysis. Further to these tests, we performed limited principal component analysis (PCA) using XLSTAT statistical software for Microsoft Excel on the data set of allergic rhinitis patients who also had asthma comparing 6 variables (TIMP1, MMP-9, Basement membrane thickness, collagen area, total blood and lymphatic vascular area) that might be associated with remodeling features. Analysis showed low variability as determined by eigenvalue, no correlation between the variables, and no positive contribution on allergic rhinitis with asthma as analysed by eigenvectors. 
Statistics
